Prihlásiť sa Zaregistrujte sa zadarmo

Quick ratio spoločnosti Starpharma

Aká je hodnota metriky Quick ratio spoločnosti Starpharma?

Hodnota metriky Quick ratio spoločnosti Starpharma Holdings Limited je 4.58

Aká je definícia metriky Quick ratio?



Quick ratio je ukazovateľ likvidity, ktorý meria schopnosť spoločnosti využiť svoje imanie na pokrytie krátkodobých záväzkov.

The quick ratio is the ratio between quick or liquid assets and current liabilities. Quick assets include those current assets that presumably can be quickly converted to cash at close to their book values. A normal liquid ratio is considered to be 1. A company with a quick ratio of less than 1 cannot at the time fully pay its current liabilities or short-term obligations. This ratio is considered to be a much reliable tool for assessment of liquidity position of companies.

Quick ratio spoločností v sektore Health Care sektor na ASX v porovnaní so spoločnosťou Starpharma

Čomu sa venuje spoločnosť Starpharma?

Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel, a non-antibiotic therapy for the management and prevention of bacterial vaginosis. It also develops VivaGel condom, an antiviral condom; and VIRALEZE, an antiviral nasal spray. In addition, the company develops DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase II clinical trials, DEP cabazitaxel that is in Phase II clinical trial, and DEP irinotecan that is in phase II clinical trials for the treatment of cancer; oncology programs, such as DEP radiopharmaceuticals, DEP HER-2 ADC, and DEP gemcitabine; DEP non-oncology candidates; and DEP AZD0466, which is in Phase I/II clinical trials to treat haematological tumours. The company was founded in 1996 and is headquartered in Abbotsford, Australia.

Firmy s metrikou quick ratio podobnou spoločnosti Starpharma